Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.80
Ask:
1.90
Spread: 0.10 (5.556%)
Market Cap: £2.18m
RDT Live PriceLast checked at - London Stock Exchange

Intraday Rosslyn Data Share Chart

Trading Statement

13 Jan 2022 07:00

RNS Number : 2786Y
Rosslyn Data Technologies PLC
13 January 2022
 

Rosslyn Data Technologies plc

("RDT", the "Group" or the "Company")

Trading update

RDT provides the following trading update.

2021 marked the start of a transformational period for Rosslyn. Following the appointment of Paul Watts as CEO in April 2021, a new leadership team has been put in place and a full operational review has been conducted in order to ensure that the business is able to provide solutions to the continually evolving needs of its customer base.

With an increased corporate focus on supply chain resilience, risk and sustainability, RDT's clients are placing more focus on procurement savings and efficiencies and the Board believes that the Group's core RAPiD product is becoming ever more relevant.

Accordingly, the Board has focused its efforts and invested heavily on developing the next generation of the Group's core RAPiD product, which it will launch before the end of March 2022. The product is currently in beta testing and the Board is extremely pleased that feedback, so far, has been overwhelmingly positive. The next generation of the RAPiD product includes, amongst other things:

· a transformation of the UI/UX interface to expand user adoption across a much broader range of procurement professionals;

· a move towards a pure best of breed cloud delivery;

· a foundation architecture built to deliver advanced intelligent automation and machine learning into the category management functions; and

· an enhancement to the product's data mining capability into a specific product called Data Factory.

Delivering growth and profitability in RDT's core market is the Board's key priority, and the operational review focused on how best to achieve this. The review identified that the Integritie and Langdon Systems acquisitions, whilst performing well since they became part of the Group, have limited crossover in terms of customer base or strategic rationale. As a result, the Board will continue to consider how to best capitalize on the Group's core business, which may include the divestment of these non-core elements of the Group, in order to deliver the best value to shareholders as a whole. The Board believes that following a strategy to enable RDT to operate as a single market data company, focused on procurement with a dynamic in-house operating model and culture will best position the Group to drive growth and deliver shareholder value in the medium to long term.

During the year, the Group has invested in its growth, with a number of key hires being made, whilst also remaining disciplined on costs and the Board will continue to explore ways to minimise costs.

The Group has made good progress so far this financial year, including winning deals for a top 10 global pharmaceutical business, a top 3 global beverage company, and a top 5 UK Law firm. At the same time, there has been a focus on exiting non-profitable business lines, to enable the Company to focus on larger, more profitable contracts. However, and as has been reported previously, larger contracts have lengthy lead times and Covid restrictions that have been experienced across the economy have lengthened these further. Whilst the Company will continue to work hard to secure further contracts before the end of the financial year, the challenges being faced, mean that the Board is taking a more conservative view on the outcome for the year ending 30 April 2022 and now expects revenue to be no less than £6.0m, with ARR to be at least £5.1m and a corresponding impact on EBITDA.

Paul Watt, CEO, commenting, "Like many businesses we have not been immune to the effects of the pandemic and this is reflected in our anticipated financial performance for the current calendar year. However, with a refreshed leadership team, a great core product and a clear strategy now in place I believe that there are significant opportunities available to the Group to drive growth and deliver shareholder value and am excited to look to the future."

 

This announcement contains inside information.

 

 

 

 

Rosslyn Data Technologies plc

Paul Watts, Chief Executive Officer

+44(0) 7555 144983+44(0)20 3285 8008

James Appleby, Chairman

+44 (0) 7940 560624

Cenkos Securities,Nominated Adviser, Broker

Stephen Keys/Camilla Hume/Giles Balleny

 

+44(0)20 7397 8900

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKLLFFLFLBBBK
Date   Source Headline
15th May 20175:29 pmRNSHolding(s) in Company
12th May 20173:00 pmRNSResult of General Meeting and Open Offer
26th Apr 20177:00 amRNSAcquisition, Proposed Placing and Open Offer
13th Mar 20175:06 pmRNSChange of Registered Office
1st Mar 20177:00 amRNSPilot Project
26th Jan 20177:00 amRNSHalf-year Report
28th Nov 20167:00 amRNSTrading Update
10th Nov 20162:31 pmRNSPartnership with Dun and Bradstreet
3rd Nov 20167:00 amRNSContract Win
10th Oct 20167:00 amRNSDirector/PDMR Shareholding
6th Oct 20163:22 pmRNSDirector/PDMR Shareholding
16th Sep 20167:00 amRNSFinal Results
12th Sep 20165:32 pmRNSHolding(s) in Company
8th Sep 201610:58 amRNSHolding(s) in Company
13th Jul 20161:28 pmRNSDirector/PDMR Shareholding
6th Jul 20167:00 amRNSFTSE 100 Company Selects Rosslyn Data Technologies
20th Jun 20167:00 amRNSBoard Re-organisation
5th May 20167:00 amRNSTrading Update
15th Jan 20162:23 pmRNSDirector/PDMR Shareholding
14th Jan 20167:00 amRNSHalf Year Results
8th Dec 20158:46 amRNSContract Wins: Top US Retailer and Legal Firm
3rd Dec 20154:09 pmRNSRule 17 Notification
17th Nov 20157:00 amRNSTrading Update
11th Nov 20154:34 pmRNSTR-1: NOTIFICATIONS OF MAJOR INTERESTS IN SHARES
4th Nov 20151:23 pmRNSExercise of Options
28th Oct 20151:18 pmRNSResult of AGM
19th Oct 20159:50 amRNSAnnual Financial Report
1st Oct 20157:00 amRNSDirectorate Change
22nd Sep 20157:00 amRNSRosslyn Deploy Data Store for Octopus Investments
18th Sep 201510:09 amRNSDirector/PDMR Shareholding
17th Sep 20157:00 amRNSAudited Results for the Year Ended 30 April 2015
11th Sep 20157:53 amRNSContract Win: Global Mining Company
14th Aug 20157:00 amRNSGenpact Announces Partnership with Rosslyn
5th Aug 20157:00 amRNSContract Wins
31st Jul 201512:43 pmRNSBoard Change
2nd Jun 201511:35 amRNSDirectors Dealings
22nd May 20155:13 pmRNSDirectors Dealings
20th May 20157:00 amRNSTrading Update and Board Change
8th May 20157:00 amRNSTwo Fortune 500 and FTSE 250 Companies Select RDT
5th May 20157:01 amRNSPwC business relationship with Rosslyn Analytics
17th Mar 20157:00 amRNSChange of Auditor
23rd Feb 20157:00 amRNSMajor Partnership in US Higher Education Sector
30th Jan 20157:00 amRNSRDT to exhibit at Innovators and Investors Forum
20th Jan 20154:15 pmRNSDirector's Dealing
20th Jan 20157:00 amRNSHalf Year Results
15th Jan 20153:10 pmRNSTR-1: Notification of Major Interest in Shares
15th Jan 20157:00 amRNSContract Win
14th Jan 20157:00 amRNSContract Win
12th Dec 20144:13 pmRNSExercise of Options
5th Dec 20141:56 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.